Name: First Choice Neurology
Price range: $$$

Larger Clinical Trial for Alzheimer’s Drug Donanemab Starting Soon

Alzheimer's / March 29, 2021

Eli Lilly’s clinical trial of the experimental drug donanemab appears to have successfully slowed cognitive decline in patients with the early symptoms of Alzheimer’s. The TRAILBLAZER-ALZ clinical trial was a

Larger Clinical Trial for Alzheimer’s Drug Donanemab Starting Soon Read More »

Alzheimer’s research

FDA Panel Recommends Full Approval for New Alzheimer’s Drug in June, Alzheimer’s & Brain Awareness Month

Larger Clinical Trial for Alzheimer’s Drug Donanemab Starting Soon

MEDICAL SERVICES

QUICK LINKS

RESOURCES